Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:269-275

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basso, C.
Right arrow Articles by Thiene, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basso, C.
Right arrow Articles by Thiene, G.
Related Collections
Right arrow Structure
Right arrow Arrythmias-basic studies
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Epidemiology

(Circulation. 2001;103:269.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Ventricular Preexcitation in Children and Young Adults

Atrial Myocarditis as a Possible Trigger of Sudden Death

Presented in part at the 72nd Scientific Sessions of the American Heart Association, Atlanta, Ga, November 7–10, 1999.

Cristina Basso, MD, PhD; Domenico Corrado, MD; Lino Rossi, MD; Gaetano Thiene, MD

From the Departments of Pathology (C.B., L.R., G.T.) and Cardiology (D.C.), University of Padua Medical School, Padua, Italy.

Correspondence to Gaetano Thiene, MD, FESC, FEACTS, Istituto di Anatomia Patologica, Via A. Gabelli 61, 35121 Padova, Italy. E-mail cardpath{at}ux1.unipd.it

Background—Sudden death (SD) in ventricular preexcitation (VP) syndrome is believed to be the result of atrial fibrillation with rapid ventricular response over the accessory pathway. Previous reports are anecdotal and often lack autopsy validation.

Methods and Results—Prevalence and clinicopathological features of VP were investigated in a series of 273 SDs in children and young adults (aged <=35 years). Site of accessory atrioventricular (AV) connection was predicted by 12-lead ECG. Right and left AV ring together with the sinoatrial and AV septal junction were studied in serial histological sections. Ten patients (3.6%; male, mean age 24±7 years) had VP: 8 had Wolff-Parkinson-White (WPW) and 2 had Lown-Ganong-Levine (LGL) syndrome. Six patients had previous symptoms, and SD occurred at rest in all but 1. Pathological substrates of LGL consisted of AV-node hypoplasia and right-sided atrio-Hisian tract, respectively. In the 8 WPW patients, 10 total accessory AV pathways consisting of ordinary myocardium were found (7 left lateral, 2 right posterolateral, and 1 septal). These pathways were close to the endocardium (mean distance, 750±530 µm) and 310±190 µm thick. In 4 WPW patients (50%), isolated acute atrial myocarditis was found, which was polymorphous in 1 and lymphocytic in 3.

Conclusions—VP accounted for 3.6% of SD in young people and was not preceded by warning symptoms in 40%. A left accessory pathway was the most frequent substrate, and its subendocardial location supports the feasibility of catheter ablation. Isolated atrial myocarditis may act as a trigger of paroxysmal atrial fibrillation that leads to SD.


Key Words: atrium • death, sudden • myocarditis • pathology • Wolff-Parkinson-White syndrome




This article has been cited by other articles:


Home page
CirculationHome page
S. Y. Ho
Accessory Atrioventricular Pathways: Getting to the Origins
Circulation, March 25, 2008; 117(12): 1502 - 1504.
[Full Text] [PDF]


Home page
EuropaceHome page
O. A. Centurion, A. Shimizu, S. Isomoto, and A. Konoe
Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff--Parkinson--White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway
Europace, March 1, 2008; 10(3): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. A. Chiale, E. Albino, H. A. Garro, H. Selva, R. J. Levi, R. A. Sanchez, M. V. Elizari, and C. B. Alvarez
Supernormal Conduction in the Anomalous Bundles of the Wolff-Parkinson-White Syndrome: An Overlooked Electrophysiologic Property With Potential Clinical Implications
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 181 - 191.
[Abstract] [PDF]


Home page
JAMAHome page
D. Corrado, C. Basso, A. Pavei, P. Michieli, M. Schiavon, and G. Thiene
Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program
JAMA, October 4, 2006; 296(13): 1593 - 1601.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Pieroni, C. Chimenti, A. Frustaci, K. Nanthakumar, Y. R. Lau, V. J. Plumb, A. E. Epstein, and G. N. Kay
Letter Regarding Article by Nanthakumar et al, "Electrophysiological Findings in Adolescents With Atrial Fibrillation Who Have Structurally Normal Hearts" * Response
Circulation, January 25, 2005; 111(3): e27 - e27.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kumagai, H. Nakashima, and K. Saku
The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model
Cardiovasc Res, April 1, 2004; 62(1): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Lavi, A. Shainberg, H. Friedmann, V. Shneyvays, O. Rickover, M. Eichler, D. Kaplan, and R. Lubart
Low Energy Visible Light Induces Reactive Oxygen Species Generation and Stimulates an Increase of Intracellular Calcium Concentration in Cardiac Cells
J. Biol. Chem., October 17, 2003; 278(42): 40917 - 40922.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Arad, I. P. Moskowitz, V. V. Patel, F. Ahmad, A. R. Perez-Atayde, D. B. Sawyer, M. Walter, G. H. Li, P. G. Burgon, C. T. Maguire, et al.
Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy
Circulation, June 10, 2003; 107(22): 2850 - 2856.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Pappone, V. Santinelli, S. Rosanio, G. Vicedomini, S. Nardi, A. Pappone, V. Tortoriello, F. Manguso, P. Mazzone, S. Gulletta, et al.
Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: Results from a large prospective long-term follow-up study
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 239 - 244.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Gollob, J. J. Seger, T. N. Gollob, T. Tapscott, O. Gonzales, L. Bachinski, and R. Roberts
Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy
Circulation, December 18, 2001; 104(25): 3030 - 3033.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]